Autopsy report · NCT03748082
Effects of Nitric Oxide on the Endothelium During Hemolysis.
Cause of deathFunding or business
“Lack of funding”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Endothelial Dysfunction; Hemolysis Intravascular; Cardiovascular Diseases; Cardiovascular Risk Factor
- Interventions
- Nitric Oxide; Reactive Hyperemia Index; Endothelial Cells Collection
- Participants
- 0
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.